Maya Khalil, MD

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - NGM Pharmaceuticals
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - Black Diamond Therapeutics
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - Shanghai Henlius
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - Dynamicure Biotech
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - Navire Pharma inc
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    SeaGen
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - I-Mab Biopharma
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027

Pages

Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology